Effect of combined treatment with methylprednisolone and Nogo-A monoclonal antibody after rat spinal cord injury

Journal of International Medical Research

Volumn 38, Issue 2, 2010, Pages 570-582

  Wu, I ^a   Yang, H ^a   Qiu, Z ^a   Zhang, Q ^a   Ding, T ^a   Geng, D ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Anti inflammatory drugs; Behaviour; Inflammation; Methylprednisolone; Nogo 66 antagonistic peptide; Rat model; Regeneration; Spinal cord injury

Indexed keywords

METHYLPREDNISOLONE; NEP 1 40; NOGO A ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MONOTHERAPY; NEUROPROTECTION; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; SCORING SYSTEM; SPINAL CORD INJURY; STRUCTURE ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77953718195     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800219     Document Type: Article

References (29)

1. Huang H, Fan S, Ji X, et al Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK. J Int Med Res 2009; 37: 511-519.
2. Baptiste DC, Fehlings MG: Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 2006; 23: 318-334.
3. Hall ED: The neuroprotective pharmacology of methylprednisolone. J Neurosurg 1992; 76: 13-22.
4. Kwon BK, Tetzlaff W, Grauer JN, et al: Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004; 4: 451-464.
5. Bracken MB: Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. Spine (Phila PA 1976) 2001; 26(24 suppl): S47-S54.
6. Hurlbert RJ: Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000; 93(1 suppl): 1-7.
7. Nadeau S, Rivest S: Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci 2003; 23: 5536-5544.
8. Yan P, Xu J, Li Q, et al: Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats. J Neurosci 1999; 19: 9355-9363.
9. Yu P, Huang L, Zou J, et al Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats. Neurobiol Dis 2008; 32: 535-542.
10. Wang F, Liang Z, Hou Q, et al: Nogo-A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal cortical infarction. Neurosci Lett 2007; 417: 255-260.
11. Wannier-Morino P, Schmidlin E, Freund P, et al: Fate of rubrospinal neurons after unilateral section of the cervical spinal cord in adult macaque monkeys: effects of an antibody treatment neutralizing Nogo-A. Brain Res 2008; 1217: 96-109.
12. Steward O, Sharp K, Yee KM, et al: A reassessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp Neurol 2008; 209: 446-468.
13. Mingorance A, Sole M, Muneton V, et al: Regeneration of lesioned entorhino-hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo-66/NgR signaling. FASEB J 2006; 20: 491-493.
14. Atalay B, Bavbek M, Ozen O, et al: Nogo-A inhibitory peptide (NEP1-40) increases pan-cadherin expression following mild cortical contusion injury in rats. Turk Neurosurg 2008; 18: 356-365.
15. Ji B, Li M, Budel S, et al: Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. EurJ Neurosci 2005; 22: 587-594.
16. Bayne K: Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. Physiologist 1996; 39:199, 208-211.
17. Schrage K, Koopmans G, Joosten EA, et al: Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury. Eur J Neuroxi 2006; 23: 285-295.
18. Gok B, Sciubba DM, Okutan O, et al Immuno-modulation of acute experimental spinal cord injury with human immunoglobulin G. J Clin Neurosci 2009; 16: 549-553.
19. Basso DM, Beattie MS, Bresnahan IC: Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996; 139: 244-256.
20. Garcia-Lopez P, Perez-Urizar I, Ibarra A, et al Comparison between Sprague-Dawley and Wistar rats as an experimental model of pharmacokinetic alterations induced by spinal cord injury. Arch Med Res 1996; 27: 453-457.
21. Huang WL, King VR, Curran OE, et al: A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007; 130 (pt 11): 3004-3019.
22. Fitch MT, Doller C, Combs CK, et al: Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 1999; 19: 8182-8198.
23. Schwartz M, Lazarov-Spiegler O, Rapalino O, et al Potential repair of rat spinal cord injuries using stimulated homologous macrophages. Neurosurgery 1999; 44: 1041-1045; discussion 1045-1046.
24. Rapalino O, Lazarov-Spiegler O, Agranov E, et al: Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 1998; 4: 814-821.
25. Popovich PG, Jones TB: Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci 2003; 24: 13-17.
26. Xu J, Qu ZX, Hogan EL, et al: Protective effect of methylprednisolone on vascular injury in rat spinal cord injury. J Neurotrauma 1992; 9: 245-253.
27. Yang YG, Jiang DM, Quan ZX, et al Insulin with chondroitinase ABC treats the rat model of acute spinal cord injury. J Int Med Res 2009; 37: 1097-1107.
28. Cao Y, Shumsky JS, Sabol MA, et al: Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil Neural Repair 2008; 22: 262-278.
29. McGee AW, Strittmatter SM: The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci 2003; 26: 193-198.